New Navigator polling reveals overwhelming bipartisan support for the Inflation Reduction Act’s cap on the price of insulin for seniors. Across political parties, race, and age groups, the support for lowering insulin costs is astoundingly clear. The price cap began on January 1, 2023 and will cap prices for 3.2 million insulin users on Medicare Part D.
As the final negotiations were being made on the Inflation Reduction Act, Republicans in the Senate unified together to make sure that the $35 insulin cap did not apply to every American with diabetes. In a country where 80 percent of diabetics have had to go into debt in order to pay for insulin, this type of action by Republicans reeks of the influence of Big Pharma. This new polling confirms that lawmakers should build on the momentum behind this provision and extend the cap so everyone is guaranteed life-saving insulin at an affordable cost.